Skip to main content
Top
Published in: Breast Cancer Research 4/2006

Open Access 01-08-2006 | Research article

Estrogenic microenvironment generated by organochlorine residues in adipose mammary tissue modulates biomarker expression in ERα-positive breast carcinomas

Authors: Mónica Muñoz-de-Toro, Milena Durando, Pablo M Beldoménico, Horacio R Beldoménico, Laura Kass, Silvia R García, Enrique H Luque

Published in: Breast Cancer Research | Issue 4/2006

Login to get access

Abstract

Introduction

Breast cancer is the most frequent malignant disease in women. Exposure to estrogens throughout a woman's life is a risk factor for the development of breast cancer. Organochlorine compounds (OCCs), such as pesticides and polychlorinated biphenyls, are persistent lipophilic chemicals identified as endocrine disruptors, mainly with estrogenic effects. To test the hypothesis that the amount and quality of organochlorine residues in adipose tissue adjacent to breast carcinoma affect the biological behavior of the tumor, we studied biomarker expression in breast carcinoma and the OCC body burden in patients from an urban area adjacent to Paraná fluvial system, Argentina.

Methods

The studied patients were 55 women who had undergone excision biopsies of a breast lesion diagnosed as invasive breast carcinoma. Analysis of OCC residues in breast adipose tissue was conducted by electron-capture gas–liquid chromatography. Estrogen receptor alpha (ERα), progesterone receptor (PR) and proliferative activity (Ki-67) levels were measured in paraffin-embedded biopsies of breast tumors by immunohistochemistry.

Results

All patients had high levels of organochlorine pesticides in their breast adipose tissue. The most frequently detected compounds were p,p'-dichlorodiphenyldichloroethylene, hexachlorobenzene and β-hexachlorocyclohexane. When the whole sample was analyzed, no correlation between ERα or PR expression and OCC levels were found. In the subgroup of ERα-positive breast carcinoma patients, however, there was a positive correlation between PR expression (an estrogen-induced protein) in the neoplastic cells and OCC levels in adipose tissue surrounding the tumor. More significantly, all the ERα-positive breast carcinomas from postmenopausal women exhibited high proliferation when organochlorine levels in the surrounding adipose tissue reached levels higher than 2600 ppb. No associations were found between the organochlorine body burden and any other marker of tumor aggressiveness, such as node involvement or tumor size.

Conclusion

The present results support the hypothesis that organochlorine residues in adipose tissue adjacent to breast carcinoma generate an estrogenic microenvironment that may influence the biological behavior of the tumor through ERα activation and ERα-dependent proliferation. These findings may have therapeutic implications, since interference between organochlorine compounds and hormonal therapy could be expected to occur.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ekbom A, Trichopoulos D, Adami HO, Hsieh CC, Lan SJ: Evidence of prenatal influences on breast cancer risk. Lancet. 1992, 340: 1015-1018. 10.1016/0140-6736(92)93019-J.CrossRefPubMed Ekbom A, Trichopoulos D, Adami HO, Hsieh CC, Lan SJ: Evidence of prenatal influences on breast cancer risk. Lancet. 1992, 340: 1015-1018. 10.1016/0140-6736(92)93019-J.CrossRefPubMed
2.
go back to reference Braun MM, Ahlbom A, Floderus B, Brinton LA, Hoover RN: Effect of twinship on incidence of cancer of the testis, breast, and other sites (Sweden). Cancer Causes Control. 1995, 6: 519-524. 10.1007/BF00054160.CrossRefPubMed Braun MM, Ahlbom A, Floderus B, Brinton LA, Hoover RN: Effect of twinship on incidence of cancer of the testis, breast, and other sites (Sweden). Cancer Causes Control. 1995, 6: 519-524. 10.1007/BF00054160.CrossRefPubMed
3.
go back to reference Weiss HA, Potischman NA, Brinton LA, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB: Prenatal and perinatal risk factors for breast cancer in young women. Epidemiology. 1997, 8: 181-187.CrossRefPubMed Weiss HA, Potischman NA, Brinton LA, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB: Prenatal and perinatal risk factors for breast cancer in young women. Epidemiology. 1997, 8: 181-187.CrossRefPubMed
4.
go back to reference Liehr JG: Is estradiol a genotoxic mutagenic carcinogen?. Endocr Rev. 2000, 21: 40-54. 10.1210/er.21.1.40.PubMed Liehr JG: Is estradiol a genotoxic mutagenic carcinogen?. Endocr Rev. 2000, 21: 40-54. 10.1210/er.21.1.40.PubMed
5.
go back to reference Wolff MS, Toniolo PG: Environmental organochlorine exposure as a potential etiologic factor in breast cancer. Environ Health Perspect. 1995, 103 (Suppl 7): 141-145.CrossRefPubMedPubMedCentral Wolff MS, Toniolo PG: Environmental organochlorine exposure as a potential etiologic factor in breast cancer. Environ Health Perspect. 1995, 103 (Suppl 7): 141-145.CrossRefPubMedPubMedCentral
6.
go back to reference Cassidy RA, Natarajan S, Vaughan GM: The link between the insecticide heptachlor epoxide, estradiol, and breast cancer. Breast Cancer Res Treat. 2005, 90: 55-64. 10.1007/s10549-004-2755-0.CrossRefPubMed Cassidy RA, Natarajan S, Vaughan GM: The link between the insecticide heptachlor epoxide, estradiol, and breast cancer. Breast Cancer Res Treat. 2005, 90: 55-64. 10.1007/s10549-004-2755-0.CrossRefPubMed
7.
go back to reference Stellman SD, Djordjevic MV, Britton JA, Muscat JE, Citron ML, Kemeny M, Busch E, Gong L: Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York. Cancer Epidemiol Biomarkers Prev. 2000, 9: 1241-1249.PubMed Stellman SD, Djordjevic MV, Britton JA, Muscat JE, Citron ML, Kemeny M, Busch E, Gong L: Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York. Cancer Epidemiol Biomarkers Prev. 2000, 9: 1241-1249.PubMed
8.
go back to reference Aronson KJ, Miller AB, Woolcott CG, Sterns EE, McCready DR, Lickley LA, Fish EB, Hiraki GY, Holloway C, Ross T, et al: Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2000, 9: 55-63.PubMed Aronson KJ, Miller AB, Woolcott CG, Sterns EE, McCready DR, Lickley LA, Fish EB, Hiraki GY, Holloway C, Ross T, et al: Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2000, 9: 55-63.PubMed
9.
go back to reference Wolff MS, Berkowitz GS, Brower S, Senie R, Bleiweiss IJ, Tartter P, Pace B, Roy N, Wallenstein S, Weston A: Organochlorine exposures and breast cancer risk in New York City women. Environ Res. 2000, 84: 151-161. 10.1006/enrs.2000.4075.CrossRefPubMed Wolff MS, Berkowitz GS, Brower S, Senie R, Bleiweiss IJ, Tartter P, Pace B, Roy N, Wallenstein S, Weston A: Organochlorine exposures and breast cancer risk in New York City women. Environ Res. 2000, 84: 151-161. 10.1006/enrs.2000.4075.CrossRefPubMed
10.
go back to reference Muñoz-de-Toro M, Beldomenico HR, Garcia SR, Stoker C, De Jesus JJ, Beldomenico PM, Ramos JG, Luque EH: Organochlorine levels in adipose tissue of women from a littoral region of Argentina. Environ Res. 2006, 102: 107-112. 10.1016/j.envres.2005.12.017.CrossRefPubMed Muñoz-de-Toro M, Beldomenico HR, Garcia SR, Stoker C, De Jesus JJ, Beldomenico PM, Ramos JG, Luque EH: Organochlorine levels in adipose tissue of women from a littoral region of Argentina. Environ Res. 2006, 102: 107-112. 10.1016/j.envres.2005.12.017.CrossRefPubMed
11.
go back to reference Gobbi H, Dupont WD, Parl FF, Schuyler PA, Plummer WD, Olson SJ, Page DL: Breast cancer risk associated with estrogen receptor expression in epithelial hyperplasia lacking atypia and adjacent lobular units. Int J Cancer. 2005, 113: 857-859. 10.1002/ijc.20632.CrossRefPubMed Gobbi H, Dupont WD, Parl FF, Schuyler PA, Plummer WD, Olson SJ, Page DL: Breast cancer risk associated with estrogen receptor expression in epithelial hyperplasia lacking atypia and adjacent lobular units. Int J Cancer. 2005, 113: 857-859. 10.1002/ijc.20632.CrossRefPubMed
12.
go back to reference Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA: Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Cancer. 2004, 101: 1490-1500. 10.1002/cncr.20499.CrossRefPubMed Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA: Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Cancer. 2004, 101: 1490-1500. 10.1002/cncr.20499.CrossRefPubMed
13.
go back to reference Demers A, Ayotte P, Brisson J, Dodin S, Robert J, Dewailly E: Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations. Cancer Epidemiol Biomarkers Prev. 2000, 9: 161-166.PubMed Demers A, Ayotte P, Brisson J, Dodin S, Robert J, Dewailly E: Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations. Cancer Epidemiol Biomarkers Prev. 2000, 9: 161-166.PubMed
14.
go back to reference Hoyer AP, Jorgensen T, Rank F, Grandjean P: Organochlorine exposures influence on breast cancer risk and survival according to estrogen receptor status: a Danish cohort-nested case-control study. BMC Cancer. 2001, 1: 8-10.1186/1471-2407-1-8.CrossRefPubMedPubMedCentral Hoyer AP, Jorgensen T, Rank F, Grandjean P: Organochlorine exposures influence on breast cancer risk and survival according to estrogen receptor status: a Danish cohort-nested case-control study. BMC Cancer. 2001, 1: 8-10.1186/1471-2407-1-8.CrossRefPubMedPubMedCentral
15.
go back to reference Woolcott CG, Aronson KJ, Hanna WM, SenGupta SK, McCready DR, Sterns EE, Miller AB: Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada). Cancer Causes Control. 2001, 12: 395-404. 10.1023/A:1011289905751.CrossRefPubMed Woolcott CG, Aronson KJ, Hanna WM, SenGupta SK, McCready DR, Sterns EE, Miller AB: Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada). Cancer Causes Control. 2001, 12: 395-404. 10.1023/A:1011289905751.CrossRefPubMed
16.
go back to reference Muscat JE, Britton JA, Djordjevic MV, Citron ML, Kemeny M, Busch-Devereaux E, Pittman B, Stellman SD: Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York. Cancer Epidemiol Biomarkers Prev. 2003, 12: 1474-1478.PubMed Muscat JE, Britton JA, Djordjevic MV, Citron ML, Kemeny M, Busch-Devereaux E, Pittman B, Stellman SD: Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York. Cancer Epidemiol Biomarkers Prev. 2003, 12: 1474-1478.PubMed
17.
go back to reference Archibeque-Engle SL, Tessari JD, Winn DT, Keefe TJ, Nett TM, Zheng T: Comparison of organochlorine pesticide and polychlorinated biphenyl residues in human breast adipose tissue and serum. J Toxicol Environ Health. 1997, 52: 285-293. 10.1080/009841097159584.CrossRefPubMed Archibeque-Engle SL, Tessari JD, Winn DT, Keefe TJ, Nett TM, Zheng T: Comparison of organochlorine pesticide and polychlorinated biphenyl residues in human breast adipose tissue and serum. J Toxicol Environ Health. 1997, 52: 285-293. 10.1080/009841097159584.CrossRefPubMed
18.
go back to reference Botella B, Crespo J, Rivas A, Cerrillo I, Olea-Serrano MF, Olea N: Exposure of women to organochlorine pesticides in Southern Spain. Environ Res. 2004, 96: 34-40. 10.1016/j.envres.2003.10.001.CrossRefPubMed Botella B, Crespo J, Rivas A, Cerrillo I, Olea-Serrano MF, Olea N: Exposure of women to organochlorine pesticides in Southern Spain. Environ Res. 2004, 96: 34-40. 10.1016/j.envres.2003.10.001.CrossRefPubMed
19.
go back to reference American Joint Committee on Cancer. AJCC Cancer Staging Manual. Edited by: Lippincott-Raven. 1997, Philadelphia, 172-177. American Joint Committee on Cancer. AJCC Cancer Staging Manual. Edited by: Lippincott-Raven. 1997, Philadelphia, 172-177.
20.
go back to reference Muñoz de Toro MM, Maffini MV, Kass L, Luque EH: Proliferative activity and steroid hormone receptor status in male breast carcinoma. J Steroid Biochem Mol Biol. 1998, 67: 333-339. 10.1016/S0960-0760(98)00124-1.CrossRefPubMed Muñoz de Toro MM, Maffini MV, Kass L, Luque EH: Proliferative activity and steroid hormone receptor status in male breast carcinoma. J Steroid Biochem Mol Biol. 1998, 67: 333-339. 10.1016/S0960-0760(98)00124-1.CrossRefPubMed
21.
go back to reference Trihia H, Murray S, Price K, Gelber RD, Golouh R, Goldhirsch A, Coates AS, Collins J, Castiglione-Gertsch M, Gusterson BA: Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors – a surrogate marker?. Cancer. 2003, 97: 1321-1331. 10.1002/cncr.11188.CrossRefPubMed Trihia H, Murray S, Price K, Gelber RD, Golouh R, Goldhirsch A, Coates AS, Collins J, Castiglione-Gertsch M, Gusterson BA: Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors – a surrogate marker?. Cancer. 2003, 97: 1321-1331. 10.1002/cncr.11188.CrossRefPubMed
22.
go back to reference Intra M, Rotmensz N, Viale G, Mariani L, Bonanni B, Mastropasqua MG, Galimberti V, Gennari R, Veronesi P, Colleoni M, et al: Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution. Cancer. 2004, 101: 905-912. 10.1002/cncr.20452.CrossRefPubMed Intra M, Rotmensz N, Viale G, Mariani L, Bonanni B, Mastropasqua MG, Galimberti V, Gennari R, Veronesi P, Colleoni M, et al: Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution. Cancer. 2004, 101: 905-912. 10.1002/cncr.20452.CrossRefPubMed
23.
go back to reference Hayes DF, Isaacs C, Stearns V: Prognostic factors in breast cancer: current and new predictors of metastasis. J Mammary Gland Biol Neoplasia. 2001, 6: 375-392. 10.1023/A:1014778713034.CrossRefPubMed Hayes DF, Isaacs C, Stearns V: Prognostic factors in breast cancer: current and new predictors of metastasis. J Mammary Gland Biol Neoplasia. 2001, 6: 375-392. 10.1023/A:1014778713034.CrossRefPubMed
24.
go back to reference Noguchi M, Ohta N, Kitagawa H, Earashi M, Thomas M, Miyazaki I, Mizukami Y: Effects of switching from a high-fat diet to a low-fat diet on tumor proliferation and cell kinetics of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats. Oncology. 1992, 49: 246-252.CrossRefPubMed Noguchi M, Ohta N, Kitagawa H, Earashi M, Thomas M, Miyazaki I, Mizukami Y: Effects of switching from a high-fat diet to a low-fat diet on tumor proliferation and cell kinetics of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats. Oncology. 1992, 49: 246-252.CrossRefPubMed
25.
go back to reference Verreault R, Brisson J, Deschenes L, Naud F, Meyer F, Belanger L: Dietary fat in relation to prognostic indicators in breast cancer. J Natl Cancer Inst. 1988, 80: 819-825.CrossRefPubMed Verreault R, Brisson J, Deschenes L, Naud F, Meyer F, Belanger L: Dietary fat in relation to prognostic indicators in breast cancer. J Natl Cancer Inst. 1988, 80: 819-825.CrossRefPubMed
26.
go back to reference Dewailly E, Dodin S, Verreault R, Ayotte P, Sauve L, Morin J, Brisson J: High organochlorine body burden in women with estrogen receptor-positive breast cancer. J Natl Cancer Inst. 1994, 86: 232-234.CrossRefPubMed Dewailly E, Dodin S, Verreault R, Ayotte P, Sauve L, Morin J, Brisson J: High organochlorine body burden in women with estrogen receptor-positive breast cancer. J Natl Cancer Inst. 1994, 86: 232-234.CrossRefPubMed
27.
go back to reference Liljegren G, Hardell L, Lindstrom G, Dahl P, Magnuson A: Case-control study on breast cancer and adipose tissue concentrations of congener specific polychlorinated biphenyls, DDE and hexachlorobenzene. Eur J Cancer Prev. 1998, 7: 135-140.PubMed Liljegren G, Hardell L, Lindstrom G, Dahl P, Magnuson A: Case-control study on breast cancer and adipose tissue concentrations of congener specific polychlorinated biphenyls, DDE and hexachlorobenzene. Eur J Cancer Prev. 1998, 7: 135-140.PubMed
28.
go back to reference Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO: The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect. 1995, 103 (Suppl 7): 113-122.CrossRefPubMedPubMedCentral Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO: The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect. 1995, 103 (Suppl 7): 113-122.CrossRefPubMedPubMedCentral
29.
go back to reference Chen CW, Hurd C, Vorojeikina DP, Arnold SF, Notides AC: Transcriptional activation of the human estrogen receptor by DDT isomers and metabolites in yeast and MCF-7 cells. Biochem Pharmacol . 1997, 53: 1161-1172. 10.1016/S0006-2952(96)00879-9.CrossRefPubMed Chen CW, Hurd C, Vorojeikina DP, Arnold SF, Notides AC: Transcriptional activation of the human estrogen receptor by DDT isomers and metabolites in yeast and MCF-7 cells. Biochem Pharmacol . 1997, 53: 1161-1172. 10.1016/S0006-2952(96)00879-9.CrossRefPubMed
30.
go back to reference Villa R, Bonetti E, Penza ML, Iacobello C, Bugari G, Bailo M, Parolini O, Apostoli P, Caimi L, Ciana P, et al: Target-specific action of organochlorine compounds in reproductive and nonreproductive tissues of estrogen-reporter male mice. Toxicol Appl Pharmacol. 2004, 201: 137-148. 10.1016/j.taap.2004.05.007.CrossRefPubMed Villa R, Bonetti E, Penza ML, Iacobello C, Bugari G, Bailo M, Parolini O, Apostoli P, Caimi L, Ciana P, et al: Target-specific action of organochlorine compounds in reproductive and nonreproductive tissues of estrogen-reporter male mice. Toxicol Appl Pharmacol. 2004, 201: 137-148. 10.1016/j.taap.2004.05.007.CrossRefPubMed
31.
go back to reference Simpson E, Rubin G, Clyne C, Robertson K, O'Donnell L, Davis S, Jones M: Local estrogen biosynthesis in males and females. 1999, 6: 131-137. Simpson E, Rubin G, Clyne C, Robertson K, O'Donnell L, Davis S, Jones M: Local estrogen biosynthesis in males and females. 1999, 6: 131-137.
32.
go back to reference Pasqualini JR: The selective estrogen enzyme modulators in breast cancer: a review. Biochim Biophys Acta. 2004, 1654: 123-143.PubMed Pasqualini JR: The selective estrogen enzyme modulators in breast cancer: a review. Biochim Biophys Acta. 2004, 1654: 123-143.PubMed
33.
go back to reference Hess-Wilson JK, Boldison J, Weaver KE, Knudsen KE: Xenoestrogen action in breast cancer: impact on ER-dependent transcription and mitogenesis. Breast Cancer Res Treat. 2006, 96: 279-292. 10.1007/s10549-005-9082-y.CrossRefPubMed Hess-Wilson JK, Boldison J, Weaver KE, Knudsen KE: Xenoestrogen action in breast cancer: impact on ER-dependent transcription and mitogenesis. Breast Cancer Res Treat. 2006, 96: 279-292. 10.1007/s10549-005-9082-y.CrossRefPubMed
34.
go back to reference Harris JR, Lippman ME, Morrow M, Osborne CK, eds: Diseases of the breast. 2000, Philadelphia, PA: Lippincott Williams & Wilkins Harris JR, Lippman ME, Morrow M, Osborne CK, eds: Diseases of the breast. 2000, Philadelphia, PA: Lippincott Williams & Wilkins
Metadata
Title
Estrogenic microenvironment generated by organochlorine residues in adipose mammary tissue modulates biomarker expression in ERα-positive breast carcinomas
Authors
Mónica Muñoz-de-Toro
Milena Durando
Pablo M Beldoménico
Horacio R Beldoménico
Laura Kass
Silvia R García
Enrique H Luque
Publication date
01-08-2006
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 4/2006
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1534

Other articles of this Issue 4/2006

Breast Cancer Research 4/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine